Torrent Pharma Vista Division Product List
• Baddi Plant received OHAS Audit certification; facility approved by the regulatory authority of Uganda • An advanced facility for Stability Studies set up at Indrad Plant • Entered into the therapeutic area of Gynaecology • Commenced commercial operations of Laboratories Torrent S.A. De C.V., Mexico • Started construction of Dahej manufacturing facility • Commissioned a subsidiary in United Kingdom and Romania • Torrent Research Center develops Long Acting Injectables technology • Foray into oncology segment •.
Babecabanga nokuthi uyahlanya ngenxa yokushumayela kwakhe ngentshiseko. Wabhala incwadi yeBhayibheli ebizwa ngokuthi uJakobe. Shablon azhurnie babochki dlya virezaniya iz bumagi. () Babengobani laba bafowabo?— Omunye wabo kwakunguJakobe.
• New manufacturing unit at Baddi, Himachal Pradesh, set up to cater to domestic formulations market. • Torrent Pharma signed an agreement with Novo Nordisk India to establish a new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk. • Acquired Heumann Pharma GmbH & Co Generica KG, a Pfizer group company, in Germany. • Two new marketing divisions- AXON and NEURON set up to cater to neuropsychiatry segment. • Entered into a research collaboration with AstraZeneca for developing novel anti-hypertensive drug. • Torrent Pharma's QC department at Chhatral manufacturing plant accredited with ISO/IEC- 17025 by NABL •.
Torrent Pharmaceuticals Ltd. Product List Acetaminophen or Paracetamol. Acetaminophen or paracetamol helps to reduce fever and to relieve a headache with mild to moderate pain. Jul 11, 2018 - Torrent Pharma launches 3 specialty divisions. Prima and Vista. Personnel in this new division to drive growth. Torrent Pharma has since long.
• Discovered and patented AGE (Advanced Glycosylation End-products) molecule. • Torrent Pharma's Indrad Plant receives ISO and OHSAS • Torrent's R&D Centre received ISO/IEC for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL). • Addition of a new marketing division, MIND • Dual Retard Inlay Technology, Compact Tablet Technology, Gastro Retentive System and Multiparticulate / Matrix Based SR / Modified Release Formulations developed indigenously by Torrent Research Center (2002) • Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award 2003 for both Formulations and API manufacturing facilities • Brazilian Sanitary Surveillance Agency accredited Torrent's R&D Centre with ANVISA, authorizing it to conduct Bioequivalance Studies.